Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · IEX Real-Time Price · USD
16.44
+0.19 (1.17%)
At close: Jul 19, 2024, 4:00 PM
16.34
-0.10 (-0.61%)
Pre-market: Jul 22, 2024, 4:00 AM EDT
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for SBRA stock have an average target of 15.68, with a low estimate of 12.5 and a high estimate of 21. The average target predicts a decrease of -4.62% from the current stock price of 16.44.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SBRA stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | -2.68% | Jun 27, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $14 → $15 | Hold | Maintains | $14 → $15 | -8.76% | May 15, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +27.74% | Jan 30, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +3.41% | Jan 3, 2024 |
| Stifel | Stifel | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | -2.68% | Nov 7, 2023 |
Financial Forecast
Revenue This Year
684.48M
from 647.51M
Increased by 5.71%
Revenue Next Year
718.80M
from 684.48M
Increased by 5.01%
EPS This Year
0.57
from 0.06
Increased by 845.20%
EPS Next Year
0.64
from 0.57
Increased by 12.59%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 725.7M | 784.9M | 825.3M | 876.2M | 928.0M |
| Avg | 684.5M | 718.8M | 746.2M | 778.7M | 901.5M |
| Low | 632.0M | 649.5M | 663.7M | 678.5M | 866.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.1% | 14.7% | 14.8% | 17.4% | 19.2% |
| Avg | 5.7% | 5.0% | 3.8% | 4.3% | 15.8% |
| Low | -2.4% | -5.1% | -7.7% | -9.1% | 11.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.61 | 0.72 | 0.68 |
| Avg | 0.57 | 0.64 | 0.66 |
| Low | 0.53 | 0.57 | 0.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 915.0% | 27.8% | 6.9% |
| Avg | 845.2% | 12.6% | 3.8% |
| Low | 782.0% | 0.2% | -0.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.